Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 137

1.

Cost-efficient vaccination protocols for network epidemiology.

Holme P, Litvak N.

PLoS Comput Biol. 2017 Sep 11;13(9):e1005696. doi: 10.1371/journal.pcbi.1005696. eCollection 2017 Sep.

2.

Continuous infusion of coagulation factor concentrates during intensive treatment.

Holme PA, Tjønnfjord GE, Batorova A.

Haemophilia. 2017 Sep 5. doi: 10.1111/hae.13331. [Epub ahead of print] Review.

PMID:
28873263
3.

Optimizing sentinel surveillance in temporal network epidemiology.

Bai Y, Yang B, Lin L, Herrera JL, Du Z, Holme P.

Sci Rep. 2017 Jul 6;7(1):4804. doi: 10.1038/s41598-017-03868-6.

4.

The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register.

Osooli M, Steen Carlsson K, Baghaei F, Holmström M, Rauchensteiner S, Holme PA, Hvitfeldt L, Astermark J, Berntorp E.

Haemophilia. 2017 May;23(3):e180-e187. doi: 10.1111/hae.13231. Epub 2017 Apr 10.

PMID:
28393468
5.

The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor.

Schultz NH, Tran HTT, Bjørnsen S, Henriksson CE, Sandset PM, Holme PA.

Thromb J. 2017 Feb 20;15:6. doi: 10.1186/s12959-017-0129-1. eCollection 2017.

6.

Expansion of cooperatively growing populations: Optimal migration rates and habitat network structures.

Yang KC, Wu ZX, Holme P, Nonaka E.

Phys Rev E. 2017 Jan;95(1-1):012306. doi: 10.1103/PhysRevE.95.012306. Epub 2017 Jan 10.

PMID:
28208365
7.

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

Berntorp E, Dargaud Y, Hart D, Lobet S, Mancuso ME, d'Oiron R, Perry D, Pollard D, van den Berg M, Blatný J, Chambost H, Doria AS, Holme PA, Kaczmarek R, Mantovani L, McLaughlin P, Nanayakkara L, Petrini P, Sannié T, Laane E, Maia R, Dettoraki A, Farrell A, Halimeh S, Raza S, Taylor S.

Eur J Haematol. 2017 Jan;98 Suppl 85:1-15. doi: 10.1111/ejh.12828.

PMID:
28101938
8.

Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe.

Holme PA, Combescure C, Tait RC, Berntorp E, Rauchensteiner S, de Moerloose P; ADVANCE Working Group.

Haemophilia. 2016 Mar;22(2):248-255. doi: 10.1111/hae.12847. Epub 2015 Dec 16.

PMID:
27880029
9.

Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study.

James PD, Mahlangu J, Bidlingmaier C, Mingot-Castellano ME, Chitlur M, Fogarty PF, Cuker A, Mancuso ME, Holme PA, Grabell J, Satkunam N, Hopman WM, Mathew P; Global Emerging HEmostasis Experts Panel (GEHEP).

Haemophilia. 2016 Nov;22(6):912-918. doi: 10.1111/hae.13089.

PMID:
27868369
10.

Trade-offs between robustness and small-world effect in complex networks.

Peng GS, Tan SY, Wu J, Holme P.

Sci Rep. 2016 Nov 17;6:37317. doi: 10.1038/srep37317.

11.

Current view and outcome of ITI therapy - A change over time?

Holstein K, Batorova A, Carvalho M, Fijnvandraat K, Holme P, Kavakli K, Lambert T, Rocino A, Jiménez-Yuste V, Astermark J; European Haemophilia Therapy Strategy Board (EHTSB).

Thromb Res. 2016 Dec;148:38-44. doi: 10.1016/j.thromres.2016.10.015. Epub 2016 Oct 15.

PMID:
27770665
12.

How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population.

Berger K, Schopohl D, Lowe G, Holme PA, Tait RC, Combescure C, Rauchensteiner S, Klamroth R.

Haemophilia. 2016 Sep;22(5):e406-16. doi: 10.1111/hae.13069.

PMID:
27650262
13.

Temporal network structures controlling disease spreading.

Holme P.

Phys Rev E. 2016 Aug;94(2-1):022305. doi: 10.1103/PhysRevE.94.022305. Epub 2016 Aug 15.

PMID:
27627315
14.

Building blocks of the basin stability of power grids.

Kim H, Lee SH, Holme P.

Phys Rev E. 2016 Jun;93(6):062318. doi: 10.1103/PhysRevE.93.062318. Epub 2016 Jun 30.

PMID:
27415291
15.

Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination.

Andre E, Isaacs C, Affolabi D, Alagna R, Brockmann D, de Jong BC, Cambau E, Churchyard G, Cohen T, Delmee M, Delvenne JC, Farhat M, Habib A, Holme P, Keshavjee S, Khan A, Lightfoot P, Moore D, Moreno Y, Mundade Y, Pai M, Patel S, Nyaruhirira AU, Rocha LE, Takle J, Trébucq A, Creswell J, Boehme C.

Int J Tuberc Lung Dis. 2016 Aug;20(8):999-1003. doi: 10.5588/ijtld.16.0015.

16.

Solving the Dynamic Correlation Problem of the Susceptible-Infected-Susceptible Model on Networks.

Cai CR, Wu ZX, Chen MZ, Holme P, Guan JY.

Phys Rev Lett. 2016 Jun 24;116(25):258301. doi: 10.1103/PhysRevLett.116.258301. Epub 2016 Jun 21.

PMID:
27391759
17.

Collective decision making with a mix of majority and minority seekers.

Holme P, Jo HH.

Phys Rev E. 2016 May;93(5):052308. doi: 10.1103/PhysRevE.93.052308. Epub 2016 May 23.

PMID:
27300911
18.

Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome.

Barratt-Due A, Fløisand Y, Orrem HL, Kvam AK, Holme PA, Bergseth G, Tjønnfjord GE, Mollnes TE.

Rheumatology (Oxford). 2016 Jul;55(7):1337-9. doi: 10.1093/rheumatology/kew040. Epub 2016 Apr 22. No abstract available.

19.

Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial.

Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, Sandvik L, Hafsahl G, Holme PA, Holmen LO, Njaaastad AM, Sandbæk G, Sandset PM; CaVenT Study Group.

Lancet Haematol. 2016 Feb;3(2):e64-71. doi: 10.1016/S2352-3026(15)00248-3. Epub 2016 Jan 6.

PMID:
26853645
20.

Connecting human behavior and infectious disease spreading: Comment on "Coupled disease-behavior dynamics on complex networks: A review" by Wang et al.

Holme P.

Phys Life Rev. 2015 Dec;15:47-8. doi: 10.1016/j.plrev.2015.10.014. Epub 2015 Oct 21. No abstract available.

PMID:
26521049

Supplemental Content

Support Center